# Recipharm Pharmaservices Private Limited – FDA Inspection, May 11, 2018

Source: https://www.keypedia.com/records/fda_inspections/recipharm-pharmaservices-private-limited/a2baf591-c4b2-4164-9b3b-be80c923d53e
Source feed: FDA_Inspections

> FDA inspection 1053644 of Recipharm Pharmaservices Private Limited, May 11, 2018. Classification: No Action Indicated (NAI). Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1053644
- Company Name: Recipharm Pharmaservices Private Limited
- Inspection Date: 2018-05-11
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1232473 - 2024-03-22
- [FDA Inspection 1119410 - 2020-02-13](https://www.keypedia.com/records/fda_inspections/recipharm-pharmaservices-private-limited/dd1ea548-d66a-4309-8ac5-8fe1a089153a)
- [FDA Inspection 1079034 - 2019-02-01](https://www.keypedia.com/records/fda_inspections/recipharm-pharmaservices-private-limited/ff968ebc-40dd-49c7-84d3-8d2080f8bc3c)
- [FDA Inspection 1075220 - 2018-12-07](https://www.keypedia.com/records/fda_inspections/recipharm-pharmaservices-private-limited/81f340a5-0e74-4b18-8dbb-cf65934bd357)
- [FDA Inspection 1037690 - 2017-12-14](https://www.keypedia.com/records/fda_inspections/recipharm-pharmaservices-private-limited/0f338ab7-111a-4a18-a919-9a24011077df)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/daniel-l-obrzut/8a0df62d-18ab-4101-9a4b-dec817a0b5d9)
- [Lata C. Mathew](https://www.keypedia.com/people/lata-c-mathew/0610a0ef-dcc5-43e7-ab74-2ac54d758beb)

Company: https://www.keypedia.com/companies/recipharm-pharmaservices-private-limited/cb3eebaa-2270-4301-a4a2-3ce95d076cd6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
